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Background: The burden of non-communicable chronic diseases, such as hypertension and diabetes, increases in
sub-Saharan Africa. However, the majority of the rural population does still not have access to adequate care. The
objective of this study is to examine the effectiveness of integrating care for hypertension and type 2 diabetes by
task shifting to non-physician clinician (NPC) facilities in eight rural health districts in Cameroon.
Methods: Of the 75 NPC facilities in the area, 69 (87%) received basic equipment and training in hypertension and
diabetes care. Effectiveness was assessed after two years on status of equipment, knowledge among trained NPCs,
number of newly detected patients, retention of patients under care, treatment cost to patients and changes in
blood pressure (BP) and fasting plasma glucose (FPG) among treated patients.
Results: Two years into the programme, of 54 facilities (78%) available for re-assessment, all possessed a functional
sphygmomanometer and stethoscope (65% at baseline); 96% stocked antihypertensive drugs (27% at baseline);
70% possessed a functional glucose meter and 72% stocked oral anti-diabetics (15% and 12% at baseline). NPCs’
performance on multiple-choice questions of the knowledge-test was significantly improved. During a period of
two years, trained NPCs initiated treatment for 796 patients with hypertension and/or diabetes. The retention of
treated patients at one year was 18.1%. Hypertensive and diabetic patients paid a median monthly amount of 1.4
and 0.7 Euro respectively for their medication. Among hypertensive patients with ≥ 2 documented visits (n = 493),
systolic BP decreased by 22.8 mmHg (95% CI: -20.6 to -24.9; p < 0.0001) and diastolic BP by 12.4 mmHg (-10.9 to
-13.9; p < 0.0001). Among diabetic patients (n = 79) FPG decreased by 3.4 mmol/l (-2.3 to -4.5; p < 0.001).
Conclusions: The integration of hypertension and diabetes into primary health care of NPC facilities in rural
Cameroon was feasible in terms of equipment and training, accessible in terms of treatment cost and showed
promising BP- and FPG-trends. However, low case-detection rates per NPC and a very high attrition among
patients enrolled into care, limited the effectiveness of the programme.
Background
The global burden of non-communicable chronic dis-
eases (NCCD) falls disproportionally on low- and mid-
dle-income countries (LAMICs), which account for 80%
of all deaths from NCCD worldwide. More than half of
these deaths in LAMICs are attributable to cardiovascu-
lar disease (CVD) and diabetes (cancer and chronic
obstructive pulmonary disease cause most of the rest)
[1,2]. Moreover, morbidity and mortality due to CVD
and diabetes are projected to grow at greatly increased
rates in developing countries over the next decades [3].
Even in Sub-Saharan Africa (SSA), where communicable
diseases still remain the major cause of death, rates of
CVD and diabetes are increasing with the associated
effects on chronic illness, mortality and disability.
Already CVD is the second leading cause of death in
SSA and the number one killer in adults older than
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ble between 1990 and 2020 in this region [4,5].
However, interventions to prevent premature deaths
due to NCCDs in LAMICs are considered to be feasible,
realistic and cost-effective [6] and the medical treatment
of hypertension and diabetes in LAMICs has been advo-
cated as a major strategy in preventing deaths due to
non-communicable diseases [7,8]. To improve coverage,
access and sustainability, primary health care in low
resource settings need to include NCCD programmes as
an integral part of the services, within the limits of avail-
able resources, and in particular nurses need to play a
major role [9].
Task shifting is the name given to a process of delega-
tion whereby tasks are moved, where appropriate, to
less specialised health workers [10]. Non-physician clini-
cians (NPCs) are health-care providers who are not
trained as physicians but who take on many of the diag-
nostic and therapeutic functions of medical doctors [11].
Recently, task shifting from physicians to NPCs has
been a key element in successful scaling up of HIV-pro-
grammes within tight budgets in several LAMICs [12].
However, there are only a few reports from Africa, not
all of the most recent date, on task shifting of the man-
agement of diabetes and hypertension in primary health
care. Moreover, those studies examined the effectiveness
in a very limited number of particularly chosen NPC-
clinics [13-15].
The aim of this study is to test, in a real-life setting,
the feasibility and effectiveness of the systematic integra-
tion of hypertension and diabetes into the primary




The study aimed at investigating the effects of a pro-
gramme that integrated the care for hypertension and
type 2 diabetes (T2D) into the existing primary health
care system by task shifting from physicians in the hos-
pitals to NPCs in health centres. The programme was
implemented in eight resource-limited Cameroonian dis-
tricts with mostly public facilities. Apart from an initial
donation of sphygmomanometers and glucose meters
and a small stock of drugs, no additional private or pub-
lic resources were made available to the providers to
maintain the activities, no medication was provided free
of charge and the focus was not only on a few high-
performance clinics or individuals.
From March 2007 to January 2008 NPC facilities were
equipped and trained for prevention, diagnosis and care
of T2 D and hypertension. The programme run under
the auspices of the Cameroon Ministry of Health with
support for initial equipment and logistics from the
Cameroon-Jura-Switzerland Cooperation and Coopéra-
tion Afrique, a Swiss non-governmental organisation. In
March 2009 the feasibility and effectiveness of this inte-
grative approach was assessed.
Study setting
The eight health districts involved in the study are situ-
ated in the Central Region of Cameroon. The combined
population is estimated at about 400’000 habitants with
about two thirds living in remote rural villages, the
others in small towns. The area is part of the Camer-
oon-Jura-Switzerland Cooperation that has been sup-
porting the districts’ primary health care activities since
1992. Contrarily to other African countries, Cameroon
does not have a specific curriculum for clinical officers.
In the health centres nurses with varying levels of edu-
cation take therefore the role of NPCs.
When the programme for hypertension and diabetes
started in 2007, there were 79 peripheral clinics in the
area offering nurse-led primary health care. Four of
these had a physician among the staff; the remaining 75
were exclusively led by NPCs. Most (78%) of the periph-
eral clinics were public where consultations are usually
free of charge but diagnostics and drugs for curative ser-
vices have to be paid out-of-pocket. The area also has
eight district hospitals and two missionary hospitals.
Intervention
The actions undertaken in the current study and the
outcomes assessed are summarised in Table 1. A preli-
minary survey was carried out in January 2007 to assess
the availability of equipment and drugs for hypertension
and diabetes in 75 (95%) of the 79 peripheral clinics.
The subsequent intervention included training, equip-
ment and supervision. Between March 2007 and January
2008 about 130 NPCs were trained during five three-day
modules. The training comprised prevention, diagnosis
and treatment of hypertension and T2 D. It was pro-
vided by four of the authors of this article (NDL, JRB,
MN, EM) and focused mainly on protocol-driven care.
Trained NPCs attended twice a year a one-day refresher
course where they presented records of their newly
identified patients.
Immediately after training, participating NPC facilities
were equipped with new sphygmomanometers, stetho-
scopes and blood glucose meters. A small initial stock
of hydrochlorothiazide (HTZ), nifedipine (NFP), metfor-
min (MF), glibenclamide (GBL) and urine-strips as well
as strips for the glucose meters were added to the regu-
lar pharmacy stocks of every facility. Similar to all other
drugs, supplies had to be renewed by the health centre
through the official drug supply system of the district.
Except for the initial stock, the programme provided no
financial support for drugs or equipment. Key aspects of
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patient-records were integrated into the protocol of the
regular supervisions carried out by the district health
committee.
In January 2008, 69 (87%) of the 79 peripheral clinics
had been fully equipped. Reasons for not equipping the
10 remaining centres were not having participated in
training (5 clinics), under-performance during training
(3) and severe non-functioning of the facility (2).
Before the start of the programme, its implementation
as well as its assessment at two years was officially
approved by the Ministry of Health, as well as by a local
panel involving physicians, nurses and community-
representatives of the eight districts. Administrative
clearance to conduct and evaluate the programme was
subsequently obtained from the Ministry of Health. For
the programme itself, no additional request to an ethical
committee was submitted. However, the applied treat-
ment protocols and procedures received ethical clear-
ance from the national ethics committee (authorisation
N°059/CNE/DNM/08) as they were submitted for a trial
that was nested within the programme described in this
paper (NCT00744458, unpublished). At data entry,
records were handled confidentially and all processed
data were anonymous.
Treatment protocols
Treatment protocols were based on international recom-
mendations [16-19] and adapted to the local conditions,
considering safety, availability and prices of drugs.
Blood pressure had to be measured manually using
new sphygmomanometers. Four measurements ≥ 140/90
mmHg after 15 minutes rest at two different days were
required before starting treatment. Depending on the
WHO grade of hypertension and the individual risk pro-
file, medical treatment was either started immediately or
an initial trial with changes in lifestyle and diet was
done. First line treatment was low-dose HCTZ (12.5 or
25 mg), to be combined with NFP if necessary. In
patients with diabetes or impaired fasting glucose, NFP
replaced HCTZ as a first-line drug. If combination ther-
apy was unsuccessful, the guidelines recommended
referral to a physician.
Blood glucose measurements had to be done using
new glucose meters that calculate the plasma equivalent
of the whole blood glucose measurement. Two fasting
blood glucose levels ≥ 7 mmol/l were required for diag-
nosis before starting treatment. Depending on the level
of fasting plasma glucose (FPG), medical treatment was
either started immediately or delayed while changes in
lifestyle and dietary habits were prescribed. If there was
no contra-indication, MF was used as a first-line ther-
apy. If monotherapy was unsuccessful or there were
contraindications to MF, GBL could be introduced.
Patients presenting with pre-coma or coma, detectable
ketone bodies in the urine and patients not responding
to dual therapy, had to be referred to a physician. Man-
agement of T2 D patients requiring insulin remained
the responsibility of physicians at a hospital level. All
drugs used are part of the Cameroonian Essential Drug
List, available over the national drug distribution system
and are sold to patients at a relatively low cost: HCTZ
50 mg (10 CFA), NFP 10 mg (10 CFA), MF 500 mg (15
CFA), GBL 5 mg (10 CFA); FPG-measurement was
taxed at 800 CFA and ketone-bodies in the urine at 200
CFA; 650 CFA equal 1 Euro.
Measured outcome variables and data-collection
Data presented in this paper originate from two points
in time: the start of the programme and the assessment
after two years. At the beginning, investigators visited
NPC-facilities for a baseline survey to check the avail-
ability of equipment and drugs essential to care for dia-
b e t e sa n dh y p e r t e n s i o n .N P C sw e r ei n v i t e dt o
Table 1 Key interventions of the programme, measured outcome-variables and their sources
Objective Activity/intervention Measured outcome Method
Assess situation and
needs
Preliminary survey of availability of equipment and
drugs
Status of equipment and drugs
for diabetes and hypertension in
2007
Investigators made inventories of




Equipment with sphygmomanometers, stethoscopes
and blood glucose meters.
Basic medication added to pharmacy stocks.
Status of equipment and drugs
for diabetes and hypertension in
2009
Investigators made inventories of
equipped health centres after
two years (2009)
Train NPCs Initial three-day training modules;
Six-monthly one-day refresher courses;
Knowledge of NPCs before,
directly after and 2 years post-
training
Multiple-choice tests before,





Checks of equipment and patient-records integrated
into the protocol of regular supervisions carried out by
the district health committee.
Numbers of patients identified,
treated and followed by trained
NPCs (2007-2009)
Change of BP and FPG among




NPC: non-physician clinicians; BP: blood pressure; FPG: fasting plasma glucose.
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choice (MC) questionnaire before and - in different
order and layout-directly after the training (pre- and
post-test).
Two years later, all 69 health centres that participated
in the programme were invited for assessment. At that
moment, the following four outcome variables were
measured (see Table 1): Status of equipment in formerly
equipped NPC-facilities; status of knowledge among
trained NPCs; number of patients identified and fol-
lowed by trained NPCs; and the trend of BP and FPG in
patients treated by trained NPCs. To assess the status of
equipment, the same checklist was used as for the
inventory in the baseline survey. Status of knowledge
was assessed with the same MC-questions as at baseline
but in different order and layout. Data on patients, the
prescribed treatment and BP/FPG trends were obtained
from standardised medical record forms, provided to
NPCs immediately after the training. These covered a
minimum of information the NPC in charge had to
enter on hypertensive or diabetic patients on every con-
sultation (BP, FPG, abdominal circumference, weight,
height and prescribed treatment). We defined abdominal
obesity as a waist circumference of ≥ 80 cm for women
and ≥ 94 cm for men, a definition already used for dif-
ferent surveys conducted in Cameroon [20]. Loss to fol-
low-up was defined as no recorded consultation for at
least three months. All patient-records available were
entered into EpiData® 3.1 by two different persons using
double entry mode in order to ensure accuracy of pro-
cessed data.
Statistical analysis
T-test and Chi2-test were used as appropriate. The per-
formance of nurses in the knowledge MC at two years
was assessed using a linear regression with the nurses’
sex, age, level of education and professional experience
being covariates. To identify reasons for lost to follow-
up, we used a cox-regression model including only
those patients who should have completed at least one
year of follow-up at the time of data-collection. Its co-
variates were the patients’ sex, age, WHO-grade of
hypertension (1,2,3), co-morbidity with diabetes and the
type of institution (missionary versus public). Treatment
response of patients was assessed as the change in BP-
or FPG-values between the visit where treatment was
started and the last recorded consultation. For analysis
of this outcome, patients not completing at least one
follow-up visit and patients with missing data during
follow-up were excluded. Univariate and multiple linear
regressions were used to estimate the crude and
adjusted delta in BP and FPG. In case of hypertension,
adjustment was done for the patients’ sex, age, abdom-
inal obesity and co-morbidity with diabetes or impaired
fasting glucose. In case of diabetes, the changes in FPG
were adjusted for sex, age, abdominal obesity and co-
morbidity with hypertension. A second multiple linear
regression model was run for BP- and FPG-changes that
includes in a addition to the first model the height of
BP (WHO-grade) or FPG (< 11 mmol/l versus ≥ 11
mmol/l) at the start of the treatment, the number of
consecutive follow-up visits and the variable pharmaco-
logical versus non-pharmacological treatment. Intraclus-
ter correlation was assessed for BP- and FPG-trends,
using generalized linear mixed models, but was found to
be small (ICC < 0.05). Therefore accounting for multi-
centre clustering has been dropped from analysis. All
reported confidence intervals are 95% intervals. Statisti-
cal analysis was performed on STATA® 10.1.
Results
Baseline
Among the 75 of the peripheral clinics that were
assessed in the preliminary survey, 49 (65%) disposed of
a well functioning sphygmomanometer and stethoscope
a n d1 1( 1 5 % )h a daf u n c t i o n a lg l u c o s e - m e t e r .T w e n t y
(27%) had at least one anti-hypertensive drug on stock
and nine (12%) at least one oral anti-diabetic. According
to the head-nurses of the facilities, 39 (52%) and 65
(87%) centres had not diagnosed, referred or treated a
single patient with high BP or diabetes, respectively,
over the last six months. The others stated to follow a
median number of 3 (interquartile range: 2-6) hyperten-
sive and 1 (1-2) diabetic patients. Drugs used to treat
hypertension and diabetes varied between facilities. For
hypertension it was mainly furosemide, alpha-methyl
dopa or diazepam; for diabetes sulphonylureas or met-
formin were used. Missionary clinics were more likely to
dispose of equipment and drugs (p < 0.01) and followed
on average more patients with either diabetes or hyper-
tension (p < 0.01).
Participation
At two years, the status of equipment was assessed in 54
(78%) of the 69 formerly equipped facilities. Fifteen cen-
tres were unavailable for the following reasons: complete
change of staff without successful handing over of activ-
ities related to hypertension and diabetes (9 centres),
transitional or permanent close-down of the facility (4)
not reachable (2). Of the 54 clinics, 46 (85%) were pub-
lic and eight (15%) were missionary health centres.
A total of 62 (48%) of the initially 130 trained nurses
participated in the knowledge-assessment at two years.
Reasons for non-participation of trained nurses in the
assessment were reallocation to other districts (42
nurses) and others (24). Reallocation of staff only con-
cerned the public facilities. The characteristics of the
assessed nurses are displayed in Table 2.
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nurses of 57 health centres and 796 (99%) were ana-
lyzed; the remaining eight had missing or non-readable
BP- or FPG-values.
Outcomes
Status of equipment in the facilities
Compared to baseline, the status of equipment was
highly improved after two years (see Table 3). Reasons
of 16 glucose meters being rated as non-functional at
two years were stock-out of compatible strips or bat-
teries (15 units) and robbery (1).
NPC state of knowledge
MC-test results before and directly after training were
available from 70 nurses and from all the 62 nurses par-
ticipating in the two-year assessment. Of these, 35% had
already participated in two, 55% in one and the remain-
ing 10% in none of the refresher courses. Knowledge
about hypertension and diabetes among nurses was
poor before training, increased directly after training
and remained high at the two-year assessment (see
Table 4). In multiple linear regression analysis, the over-
all test-performance at two years was independent of
the nurses’ sex, age, medical education and professional
experience.
Recruited Patients
The number of recruited patients per trained NPC var-
ied from one to 51. Table 5 displays characteristics of
the 796 patients of whom data were analyzed. Forty-one
(28%) of the diabetic and 192 (27%) of hypertensive
patients were aware of their condition and declared hav-
ing once received treatment in another facility, but none
was under medical treatment at the moment they were
diagnosed by the NPCs. In the 54 facilities where pre-
and post-intervention data are available, the median
number of patients per facility with hypertension
increased from 0 (interquartile range 0-2) to 14.5 (7-22)
and from 0 (0-0) to 3 (1-6) for diabetes.
A total of 2579 visits and a follow-up time of 222
patient-years were recorded. Of the 796 patients, 562
(70.6%) were lost to follow up at the time data were col-
lected (no recorded visit since ≥ 3 months). Before
dropping out, these patients completed a median num-
ber of 2 visits (interquartile range: 1-3) and a median
follow-up time of 28 days (0-92). Among the patients
who were recruited at least 15 months before the assess-
ment (n = 349), only 18.1% were still retained in the
programme at one year (see Figure 1). In a cox regres-
sion model none of the assessed patient-characteristics
was associated with the risk of being lost to follow-up at
one year. However, patients of missionary clinics were
at higher risk of being lost to follow-up (see Table 6).
Prescribed treatment and BP-changes in hypertensive
patients
All 732 patients with hypertension received counselling
on diet and lifestyle. NPCs prescribed at the first visit
hydrochlorothiazide monotherapy to 317 (43.3%), nifedi-
pine monotherapy to 114 (15.6%) and bitherapy to 120
(16.4%) patients. The remaining 181 (24.7%) were on
diet and lifestyle change alone. At the last visit recorded,
the NPC prescribed to 272 (37.2%) hydrochlorothiazide
monotherapy, to 103 (14.1%) nifedipine monotherapy
and to 236 (32.2%) a bitherapy. The remaining 121
(16.5%) were still on non-pharmacological treatment
alone. Patients on medication paid a median monthly
amount of 1.4 Euro (interquartile range 1.2-1.5) for the
prescribed anti-hypertensive drugs.
The 493 hypertensive patients with at least one docu-
mented follow-up visit were included in analysis of BP-
change. This cohort has a median follow-up of 102 (35-
240) days with a median of 3 (2-6) documented visits.
Fifty-five patients (11%) in the cohort were still on non-
pharmacological treatment alone at the last visit
recorded. Unadjusted overall systolic BP decreased by
22.8 mmHg (95% CI: -20.6 to -24.9) and diastolic BP by
12.4 mmHg (95%CI: -10.9 to -13.9). Figure 2 displays
the BP at baseline (initiation of treatment) and at the
last consultation by WHO grade of hypertension at the
first visit. Adjusted for patient-characteristics (sex, age,
abdominal obesity, co-morbidity with diabetes or
impaired fasting glucose) the BP-decrease remained
Table 2 Characteristics of the 62 non-physician clinicians
participating in the knowledge assessment at two years.
Age (standard deviation) 44 (8)
Sex Female 26%
Level of medical education Nurse assistant 13%
Staff nurse 31%
Registered nurse 56%
Years of professional experience (SD) 18 (9)
Years working at the current institution (SD) 6 (5)
Table 3 Inventory of equipment and drugs in the 54





Equipped to measure BP 67% 100%
Functional glucose meter 14% 70%
At least one anti-hypertensive
drug
20% 96%
A least one oral anti-diabetic
drug
12% 72%
Equipped to measure BP was defined as having a sphygmomanometer and a
stethoscope without leakages or any other visible damages. A functional
glucose meter meant that the battery was working and that compatible strips
were available. BP: blood pressure.
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tolic and -17.2 mmHg (95%CI: -7.1 to -27.3) for diasto-
lic BP.
In the second model of multiple linear regression analy-
sis, higher initial WHO-grade of hypertension (coeffi-
cients: grade 1 to grade 2: -9.2 (CI95%: -3.7 to -14.8);
grade 1 to 3: -27.3 (95%CI: -21.7 to -32.9)) and a greater
number of consecutive consultations (coefficient: -1.3; 95%
CI: -0.6 to -1.9) were significantly associated with a greater
decrease in systolic BP. The patients’ sex, age, co-morbid-
ity with diabetes, abdominal obesity, impaired fasting glu-
cose and pharmacological treatment were not significantly
related. The same model for the diastolic BP-trend showed
a similar result with WHO-grade (coefficients: grade 1 to
2 :- 4 . 5( - 0 . 1t o- 8 . 9 ) ;g r a d e1t o3 :- 1 1 . 3( 9 5 % C I :- 6 . 9t o
-15.7)) and the number of consultations (coefficient: -0.9
(-0.3 to -1.5)) being the only two covariates significantly
associated with diastolic BP-decrease.
Prescribed treatment and FPG-change in diabetic patients
All of the 144 patients with diabetes received counsel-
ling on diet and lifestyle. At the first visit, NPCs pre-
scribed to 67 (46.5%) metformin and to 2 (1.4%)
glibenclamide. At the last consultation recorded, the
NPCs prescribed to 72 (50%) metformin monotherapy,
to 2 (1.4%) glibenclamide monotherapy and to 9 (6.3%)
bitherapy. The remaining patients were still on diet and
lifestyle change alone. Patients on medication paid a
median monthly amount of 0.7 Euro (interquartile
range: 0.7-2.1) for the prescribed anti-diabetic drugs.
Of the total of 144 diabetic patients 94 (65%) com-
pleted at least one follow-up visit. Only the 79 (55%)
patients where FPG-values at baseline as well as at the
last consultation are available were included in the ana-
lysis of FPG-change. This cohort has a median follow-
up time of 72 (23-243) days with a median of 3 (2-6)
documented consultations; 15 (19%) were still on non-








Knows that diabetes is diagnosed based on FPG 93% 100% 94%
Knows BP levels defining arterial hypertension 20% 80% 69%
Chooses a correct drug for first line treatment of hypertension 17% 94% 95%
Chooses an antihypertensive drug that is not contra-indicated for treatment during pregnancy 27% 97% 82%
Chooses lifestyle and diet modifications for the treatment of IFG 73% 97% 97%
Chooses the correct protocol for moderate diabetes (FPG 7-10.9 mmol/l) 30% 44% 47%
Chooses the correct protocol for severe diabetes (FPG > 11 mmol/l) 23% 76% 79%
Chooses to search for ketone bodies in the urine in case of very high blood glucose levels 41% 96% 95%
Chooses the right patients who must be referred immediately to a hospital (coma and ketoacidosis) 46% 54% 58%
BP: blood pressure; FPG: fasting plasma glucose
Table 5 Characteristics of the 796 newly recruited
patients in 57 NPC facilities.
Patient characteristics
Sex Female 69%
Age in years (standard deviation) 60 (12)
Abdominal Obesity 52.3%
Patients with hypertension (n = 732)
- WHO Grade 1 (140-159/90-99 mmHg) 25.2%
- WHO Grade 2 (160-179/100-109 mmHg) 35.3%
- WHO Grade 3 (≥ 180/110 mmHg) 39.5%
- Hypertension and IFG 18.7%
Patients with diabetes (n = 144)
- FPG 7-10.9 mmol/l 52.8%
- FPG ≥ 11 mmol/l 47.2%
- Co-morbidity with diabetes and hypertension 61.8%
Abdominal obesity was defined as a waist circumference ≥ 80 cm for women
and ≥ 94 cm for men. FPG: Fasting plasma glucose; IFG: Impaired fasting
glucose (5.6-6.9 mmol/l).
n = 349
















0 100 200 300 400
Days of follow-up
Figure 1 One-year retention of diabetic and hypertensive
patients. Attrition among the 349 patients who were recruited at
least 15 months before the assessment. Lost to follow-up was
defined as no recorded consultation for ≥ 3 months.
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recorded. Unadjusted overall FPG decreased by 3.4
mmol/l (95% CI: -2.3 to -4.5; p < 0.001). Adjusted for
patient-characteristics (sex, age, abdominal obesity,
co-morbidity with hypertension) the FPG-decrease
remained significant at -7.8 mmol/l (95%CI: -1.8 to
-13.8). As shown in Figure 3, those with a higher initial
FPG showed a steeper decrease.
In the second model of multiple linear regression ana-
lysis, high initial FPG-levels (coefficient < 11 mmol/l
versus ≥ 11 mmol/l: -3.8 (95%CI: -1.2 to -6.4)) and a
higher number of consultations (coefficient: -0.4 (95%CI:
-0.1 to -0.7)) were significantly associated with a greater
decrease of blood glucose levels. The other covariates
(sex, age, co-morbidity with hypertension, abdominal
obesity and pharmacological treatment) showed no sig-
nificant relation with FPG-changes.
Discussion
Cameroon, like most of SSA, faces a looming epidemic of
arterial hypertension and diabetes which will put an
immense strain on the general primary health care sys-
tem over the years to come [21,22] but for which so far
very few resources have been dedicated by the WHO and
other big international donors [23]. The country is taking
measures to combat the raising numbers of cases: Jean-
Claude Mbanya, president of the International diabetes
Federation, initiated the Cameroon Burden of Diabetes
project (CAMBoD), which conducted important baseline
surveys, numerous awareness activities and installed pilot
clinics. This paved the way to a national programme in
2004 that aims to promote equitable access to quality
health services in order to reduce the morbidity and
mortality linked to diabetes and hypertension [24].
Table 6 Assessed patient-characteristics and their
association to the risk of being lost to follow-up at one
year.




Sex 1.08 (0.82 to 1.41) 0.590
Age 1.00 (0.99 to 1.01) 0.653
Diabetes 0.81 (0.56 to 1.17) 0.262
WHO-grade of
hypertension
0.93 (0.80 to 1.07) 0.315
Missionary facility 1.74 (1.19 to 2.53) 0.004
Hazard-ratios and p-values are derived from a cox regression with lost to
follow-up at one year being the dependent variable.
WHO Grade 1  WHO Grade 3  WHO Grade 2 
Figure 2 Change of blood pressure among hypertensive
patients. Changes in systolic and diastolic blood pressure between
the visit where treatment was started (usually the second visit) and
the last follow-up visit. Dots are displaying mean values, bars the
95% confidence interval. Groups are according to the WHO grade of
hypertension at initiation of therapy. Grade 1 n = 82; grade 2 n =
160; grade 3 n = 196). All changes are significant (p < 0.001).
7 to 10.9 mmol/l at treatment start ≥ 11 mmol/l at treatment start
Figure 3 Change of fasting plasma glucose among diabetic
patients. Change in fasting plasma glucose levels between the visit
where treatment was started (usually the second visit) and the last
follow-up visit among diabetic patients. Dots are displaying mean-
values, with brackets indicating the 95% confidence interval. The
changes in both groups are significant (sample with 7-10.9 mmol/l
at the start of the treatment (n = 35), p-value = 0.0151; sample
with≥ 11 mmol/l at the start of the treatment (n = 44), p < 0.001).
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betes in Cameroon are still not aware of their condition
and do not have access to qualified care [25,26].
Our study highlights some of the enormous difficul-
ties, not all of economic nature, faced by primary health
care programmes for chronic diseases in SSA countries.
As the preliminary survey conducted at the start of our
research showed, the majority of health centres in rural
Cameroon currently neither dispose of adequate equip-
ment and drugs, nor do caregivers possess the necessary
knowledge to recognise, diagnose and treat hypertension
and diabetes. The experiences from our programme
indicate that task shifting on a primary health care level
is indeed feasible within the available resources in
Cameroon: NPCs were trained and equipped with rela-
tively few efforts to efficiently care for patients with
hypertension and T2 D. But despite significantly
improved clinical outcomes on BP and FPG, the overall
effectiveness of the programme was modest because of
limited access to patients and a very high drop out rate.
There are four major limitations to be considered in
the interpretation of the reported BP- and FPG-changes:
first, we describe BP- and FPG-trends originating from
routinely filled in medical record forms; second, baseline
BP- and FPG-values originate from the measurement
when treatment was started (usually at the second visit).
Studies have shown, that measurements at the first or
second visit may overestimate the degree of arterial
hypertension [27]. Third, our cohort cannot be com-
pared to a control group; Fourth, the overall time of fol-
low-up is short. The very positive trend in BP- and
FPG-values in this cohort has therefore to be interpreted
with caution as it may partly be due to a natural regres-
sion to the mean.
From an operational point of view, there are another
three very important limitations in the assessment of
t h ep r o g r a m m e .F i r s t ,o n l yd a t af r o m7 8 %o ff o r m e r l y
equipped facilities and 48% of formerly trained NPCs
were available for analysis. Most of the drop-out of cen-
tres and NPCs were due to changes of staff and/or
transfer to new facilities. It is part of the national health
policy to move the staff in public health care facilities
regularly. Experience from our programme has shown,
that after change among the staff in a facility, the pro-
gram often becomes un-functional. Constant training of
staff newly allocated to the facilities has therefore to be
done. This can currently only be done with support
from external donors and poses a big challenge to sus-
tainability. To strengthen the teaching about care for
hypertension and diabetes at a national level during the
basic training curriculum of nurses and to extend the
programme on a national level may on the long run
contribute to sustainability. Second, the nurses’ knowl-
edge was only assessed through multiple-choice
questionnaires and does not necessarily reflect their
medical practice. However, an independent observa-
tional assessment of practice would have been too
resource-intensive to our study. Third, we do not have
any information about what happened to the patients
lost to follow-up. Indeed, in regression analysis basic
patient-characteristics were not related to the risk of
being lost to follow-up. However, to interpret these find-
ings, more data about the patients, such as their socio-
economic status or their distance to the facility, is
needed. Moreover, a subsequent retracing with an
assessment of their outcomes and the reasons for attri-
tion would be of great importance to improve the
programme.
Several recent studies show that integrated nurse-led
care for HIV/AIDS can be effective even on a large scale
[12] and evidence is growing that task shifting may also
work for other chronic conditions, such as epilepsy [28].
It is unclear how far these promising results can be gen-
eralised to asymptomatic chronic diseases, but it is clear
that some problems will be the same, most importantly
perhaps low retention rates [29]. Similar to our work,
s t u d i e so nh y p e r t e n s i o na n ddiabetes programmes from
Dar es Saalam and Soweto respectively report very low
adherence and retention rates as main challenges
[30,31]. Two papers that were recently published,
describe a cohort of diabetic and hypertensive patients
followed between 1998 and 2000 in five NPC-facilities
in Cameroon [14,15]. Similarly to our study, they report
high attrition rates, especially during the first three vis-
its. Patients from rural clinics and patients who were
recruited through particular awareness- and screening-
activities were more likely to remain retained. Awah et
al. report from Cameroon, that culturally affected illness
and treatment perceptions play a major role in attrition
and adherence of diabetic patients. While modern medi-
cine only provides care and control for diabetes, many
patients seem to seek definite cure in traditional medi-
cine [32]. However, one must assume that a high attri-
tion rate will remain a main challenge to the
effectiveness of programmes for chronic conditions on a
larger scale in SSA. Further research on how to improve
retention is urgently needed.
We are not aware of any publication that tested task
shifting on a larger scale within the framework of exist-
ing resources for hypertension and diabetes in low-
income African countries. Kengne et al. demonstrate a
successful task shifting for diabetes and hypertension in
three urban and two rural clinics in Cameroon. How-
ever, the experience is limited on five clinics and a high
proportion of included patients were urban [14,15]. In
contrast, we examined a district-wide integration with-
out additional resources into existing rural NPC clinics
that have originally been set up to care for acute
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Page 8 of 10infectious diseases, a situation mirroring the current
reality in the field.
While acknowledging the high importance of low
retention rates, our data still show, that such an integra-
tive approach is a feasible option in settings with low
resources to respond to the need for accessible care
among the raising number of individuals with hyperten-
sion and diabetes. Hypertensive and diabetic patients
paid for their medication a median monthly amount of
1.4 and 0.7 Euro respectively. Indeed, these amounts
may still be too high for some patients in a country
where poverty is wide spread. However, we can assume
that for a high number of hypertensive and diabetic
individuals in the study area, treatment has now become
affordable. Most patients reached by our programme
were unaware of their condition even though a consid-
erable number had severe hypertension (grade 3) or dia-
betes with high FPG levels. In the majority of these
participating patients, BP and/or FPG were reduced
sharply during follow-up. Thus the potential public-
benefits even of modestly successful programmes may
be substantial.
However, if policy makers aim at task-shifting as an
integrative approach for NCCDs on a large scale, pro-
blems encountered in this study should be taken into
account: 1, Frequent reallocations of trained staff out-
side the study area with subsequent cessation of the
activities related to diabetes and hypertension in some
of these facilities; 2, Interruptions in the supply of oral
anti-diabetics and strips for glucose meters; 3, low
detection rates per trained and equipped NPC; and 4, a
very high proportion of loss to follow-up among treated
patients. While the first two points may be a problem of
management, the issue of detection and attrition point
to a general problem of access to care and retention in
many primary health care systems in SSA. Integrated
programmes for chronic diseases might provide a good
opportunity to identify these problems and to take mea-
sures to strengthen the health system in general.
Further research in this field should include the fol-
lowing topics: comparison of patient outcomes between
nurse-led and physician-led care, examination of the
reasons for lost to follow-up, assessment of drug-adher-
ence, trials testing simple interventions to improve
retention and a long time cohort study with sufficient
power to measure harder outcomes (i.e. stroke inci-
dence, amputation-rate, mortality, etc.).
Conclusions
The programme aimed at integrating the care for hyper-
tension and diabetes into the daily routine of nurse-led
primary health care in rural Cameroon. It worked within
the given framework of the national public health sys-
tem and except for training and initial equipment no
additional resources were allocated. The presented data
of the two-year assessment suggest that such an
approach is feasible and that trained NPCs may treat
these two conditions successfully, using affordable drugs
from the national essential drug list. However, the aver-
age case-detection rate per trained NPC was low and a
very high attrition among treated patients poses the
main challenge.
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